眼整形手术中出血及围手术期出血并发症的危险因素:一项前瞻性先导研究
该前瞻性先导研究纳入324例眼整形手术患者,采用标准化问卷评估出血史,发现严重出血与问卷评分较高、眼睑手术中使用乙酰水杨酸、糖尿病、肾病、全身麻醉及手术时间较长显著相关。结论认为该问卷是评估出血风险的有价值工具,支持未来开展多中心研究以制定围手术期抗血小板/抗凝管理指南。
要点
- 标准化问卷评分较高与出血并发症显著相关(p=0.048)。
- 眼睑手术中使用乙酰水杨酸(p=0.038)、糖尿病(p=0.016)、肾病(p=0.044)、全身麻醉(p=0.001)及较长手术时间(p=0.007)与出血显著相关。
- 局部麻醉、抗凝药使用及收缩期高血压与出血风险无显著关联。
核心结论
- 标准化问卷是评估眼整形患者出血风险的有价值工具。
- 研究结果支持未来开展多中心研究以制定基于证据的抗血小板和抗凝围手术期管理指南。
研究设计与样本
- 前瞻性先导研究,纳入324例年龄18-92岁的眼整形手术患者,包括252例眼睑手术、56例眼眶手术和16例鼻泪管手术。
- 采用标准化问卷收集患者出血史,评估问卷评分与术前/人口学因素及手术因素之间的关联,并使用评分系统量化出血严重程度。
- 术后监测24小时(眼睑手术)至3或4天(眼眶/鼻泪管手术)。
主要发现
- 87例患者使用抗血小板药、抗凝药和/或草药补充剂。
- 35例发生严重出血,其中4例需要修正手术,但无人遭受永久性损害。
- 出血并发症与较高的标准化问卷评分显著相关(p=0.048)。
- 出血并发症与眼睑手术中使用乙酰水杨酸(p=0.038)、糖尿病(p=0.016)、肾病(p=0.044)、全身麻醉(p=0.001)及较长手术时间(p=0.007)显著相关。
- 局部麻醉、抗凝药使用及收缩期高血压与出血风险无显著关联。
临床怎么用
- 原文未据此给出推荐。
局限性
- 队列异质性。
- 样本量小。
- 非盲法设计。
- 主观出血评分影响可比性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND/AIMS: Clear guidelines for managing patients on antiplatelet (AP) or anticoagulant (AC) therapy undergoing oculoplastic surgery are lacking. This study investigates bleeding risk factors and evaluates the effectiveness of a standardised bleeding risk assessment in extraocular surgery. METHODS: In this prospective study, a standardised questionnaire (SQ) was employed to gather patients' bleeding histories. Associations between SQ scores and preoperative/demographic factors (AP/AC use, age, sex, comorbidities), and surgical factors (blood pressure, surgery type, primary vs revision surgery, anaesthesia type, duration, pain management) were assessed. A scoring system quantified bleeding severity. Patients were monitored postoperatively for 24 hours (eyelid procedures) to 3 or 4 days (orbital/nasolacrimal surgery). RESULTS: A total of 324 patients (aged 18-92) were included (252 eyelid, 56 orbital and 16 nasolacrimal surgeries). 87 patients were using AP, AC and/or herbal supplements. Severe bleeding occurred in 35 patients, four required revision surgery, though none suffered permanent damage. Bleeding complications were significantly associated with higher SQ scores (p=0.048), acetylsalicylic acid use in eyelid surgery (p=0.038), diabetes mellitus (p=0.016), renal disease (p=0.044), general anaesthesia (p=0.001) and longer surgery duration (p=0.007). Local anaesthesia, AC use and systolic hypertension were not significantly associated with bleeding risk. CONCLUSION: The SQ is a valuable tool for assessing bleeding risk in oculoplastic patients. Findings support future multicentre studies to develop evidence-based perioperative guidelines for AP and AC management. Limitations include cohort heterogeneity, small sample size, non-blinded design and subjective bleeding scores affecting comparability.
引用
- Christensen NA, Feltgen N, Horn M, et al. Risk factors for bleeding and perioperative bleeding complications in oculoplastic surgery: a prospective pilot study. Br J Ophthalmol. 2025. PMID: 40695569. doi:10.1136/bjo-2024-326553
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。